Sino Biopharmaceutical Ltd
01177: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$9.31 | Mxq | Rjgxzdjv |
Sino Biopharmaceutical: Placing Coverage Under Review
We are placing coverage of narrow-moat-rated Sino Biopharmaceutical under review pending the transfer of coverage to a new analyst. We expect to revisit our coverage of this company over the next three months. Our most recent fair value estimate was HKD 6.50.